|


TEL: +32 16 58 90 45
Fax :+ 32 16 50 90 45
GENTAUR Europe
tel+32 2 732 5688
fax+32 2 732 4414
Av.
de l' Armée 68
B-1040 BRUSSELS
BELGIUM

GENTAUR France
tel 01 43 25
01 50
fax01 43 25
01 60
9, rue
Lagrange
75005 PARIS
FRANCE

GENTAUR Italy
tel 02 36 00
65 93
fax 02 36 00
65 94
20135 MILANO
ITALY

GENTAUR Germany
tel +49 241
6085 13140
fax +49 241
6085 33033
Forckenbeckstraße 6,
D-52074
Aachen
GERMANY
| |
Malondialdehye (MDA),
4-Hydroxy-2-Nonenal (HNE), Nitrated Tyrosine
and 8-hydroxyguanosine (8-OHG), and S-Nitroso-Cys (SNO-Cys) Antibodies
|
Items |
Antigen |
Ab
Host |
Species reactivity |
Antiserum
Cat # 100 ul |
Aff Pure IgG/Mono
Cat # 100 ug |
|
MDA Compound
For modifiction of proteins |
Malondialdehyde (MDA)-bis(dimethyl acetal) solution
Cat # MDA51-10; 10 ml |
|
Anti-MDA (ab # 1) |
MDA-KLH |
Poly, Rb |
All species |
MDA11-S |
|
|
Anti-MDA (ab # 2) |
MDA-KLH |
Poly, G |
All species |
MDA12-S |
|
|
HNE Related Products
|
|
HNE-Compound
For modification of proteins |
4
hydroxynonenal (HNE), >98% pure; Cat # HNE51-5; 5 mg
4 hydroxynonenal (HNE), >98% pure; Cat #
HNE51-10; 10 mg |
|
Anti-HNE (ab # 1) |
HNE-KLH |
Poly, Rb |
All species |
HNE11-S |
|
|
HNE-BSA Conjugate control #1
|
For Western blot (supplied in Sample buffer, reduced),
Cat # HNE11-C; 100 ul |
|
Anti-HNE (ab # 2)
|
HNE-KLH
|
Poly, G
|
all species
|
HNE12-S
|
|
|
HNE-BSA Conjugate control #2
|
For Western blot (supplied in Sample buffer,
reduced), Cat # HNE12-C; 100 ul
|
|
HNE-BSA Conjugate control #2
|
For ELISA, stds or WB (supplied in PBS
buffer), Cat # HNE15-R; 100 ug
|
|
Nitrotyrosine Related Products
|
|
Nitrated-Tyrosine
(ab # 1) |
Nitrated-KLH |
mouse
mono |
all species |
|
NITT11-M |
|
Nitrated-Tyrosine
(ab # 2) |
Nitrated-KLH |
Poly, Rb |
all species |
|
NITT12-A |
|
Nitrated-Tyrosine
(ab # 3) |
Nitrated-KLH |
Poly, G |
all species |
NITT13-S |
|
|
Nitrated Proteins control |
Nitrated Mol. Wt protein Standard for Western, Cat #
NITT12-C, 100 ul |
|
Nitrated Proteins control
|
Nitrated BSA
protein For Standard or ELISA etc, Cat # NITT15-N, 100
ug
Nitrated Ovalbumin protein For Standard
or ELISA etc, Cat # NITT16-N, 100 ug
|
|
Nitroso-Cysteine
(SNO-Cys)
|
Nitroso-Cysteine
-KLH
|
Poly, Rb
|
all species
|
. |
NISC11-A
|
|
S-Nitrosoylated-BSA protein
Conjugate (Control)
|
S-Nitrosoylated-BSA Protein Conjugate for
ELISA or antibody blocking
Cat # SNOBSA-N-100 (100 ug)
|
|
8-OH Guanosine Related Products
|
|
8-Hydroxyguanosine Chemical |
8OHG |
8-Hydroxy Guanosine ;
Cat # 8OHG15-N-1; 1 mg
8-Hydroxy Guanosine ; Cat # 8OHG15-N-5; 5 mg
|
|
8-Hydroxyguanosine (8-OHG) ab # 1 |
8OHG-BSA/ |
M,
mono |
all species |
|
8OHG11-M |
|
8-Hydroxyguanosine (8-OHG) ab # 2 |
8OHG-BSA |
Poly, G |
all species |
8OHG12-S |
|
M= Mouse; R=Rat; H=Human; Rb=Rabbit; G=goat; B=Bovine, MO=Monkey; P=pig; CT=
near C-terminus; NT=near N-terminus; Internal=Middle of protein.
EC=extracellular; CP=cytoplasmic domains *
Malondialdehye (MDA), 4-Hydroxy-2-Nonenal (HNE), Nitrated Tyrosine and
8-hydroxyguanosine (8-OHG), and S-Nitroso-Cys (SNO-Cys) Antibodies-General
Information
MDA is a physiological compound produced by
peroxidative decomposition of unsaturated lipids as a by-product of arachidonic
metabolism. Under normal conditions, MDA is quickly oxidized to acetate or
malonate and then to CO2 via TCA cycle. Excessive production of MDA, as a result
of tissue injury and DNA-damage, could combine with free amino groups of
proteins resulting into MDA-modified protein adducts. Modifications of proteins
by MDA could conceivably alter biological properties of proteins. Moreover,
MDA-modified protein may serve as an antigen and invoke production of
autoantibodies and subsequent destruction of MDA-modified proteins. An
uncontrolled diabetes mellitus is known to be associated with high free radical
activity. Injections if streptozotocin has been shown to induce MDA-modified
proteins in the plasma. MDA-modified LDL shows altered behavior and is entrapped
in arterial walls. Autoantibodies to MDA-LDL have been detected in human and
rabbits sera. Moreover, alcohol fed rats and alcoholics have autoantibodies to
acetaldehyde. Further progress in this field is hampered by the availability of
anti-MDA antibodies.
Among
the aldehyde which originate from the peroxidation of cellular membrane lipids,
4-hydroxy-2-nonenal (HNE) is the major aldehyde
generated by free radical attack on w-6 polyunsaturated fatty acids. HNE is
largely responsible for pathogenesis during oxidative stress. HNE is highly
reactive towards free sulfydryl groups of proteins producing thioether adducts
that further undergo cyclization to form hemiacetals. HNE also reacts with
histidine and lysine residues of proteins to form stable Michael addition-type
adducts. HNE induces heat shock protein, inhibits cellular proliferation and
highly toxic to cells. It exhibits genotoxic and mutagenic effects as well.
Elevated levels of HNE modified nigral neurons were also observed in Parkinson
disease.
Reactive oxygen species (ROS) are formed at high levels as by-products of the
normal cellular metabolism. Both nuclear and Mitochondrial DNA has been shown to
accumulate high levels of 8-hydroxy-2'-deoxyguanosine, a very stable and
damaging product of hydroxylation of guanine at carbon 8.
8-hydroxyguanosine (8-OHG) induces transversion of G to T, which is
potentially mutagenic. The base excision repair (BER) pathway is the most
important cellular protection mechanism responding to oxidative DNA damage. They
remove modified DNA bases before they are incorporated into DNA during
replication. The key enzymes MutT homologs (MutT/MTH) in the BER process are DNA
glycosylases, which remove different damaged bases by cleavage of the
N-glycosylic bonds between the bases and the deoxyribose moieties of the
nucleotide residues. The 8-oxoG glycosylases (Fpg or MutM/OGG) and the MutY
homologs (MutY/MYH) glycosylases along with MutT/MTH protect cells from the
mutagenic effects of 8-oxoG. 8-hydroxyguanosine (8-OHG) has been used as
oxidative stress marker.
Nitric oxide (NO) and reactive oxygen species (ROS) are important mediators to
produce harmful or protective functions. NO can react with superoxide anions
(O2.-), yielding the toxic oxidizing agent peroxynitrite (ONOO-). Peroxynitrite
induces nitration of tyrosine residues
leading to changes of protein structure and
function, and alterations in signaling pathways. Antibodies to nitrotyrosine
have been used to monitor the status of peroxynitrite-induced modification of
proteins.
S-nitrosylation of cysteine thiols in proteins by
the highly labile NO radical has been identified as a important effectors of
NO-related bioactivity both in NOS-containing cells and intercellular signaling.
Most cells contain low levels of nitrosylated proteins that are thought to be
regulated by S-nitrosylation and denitrosylation. S-nitrosylation of proteins
serves as a ubiquitous post-translational modification that dynamically
regulates a broad functional spectrum of proteins. The majority of these
proteins are regulated by S-nitrosylation on a single critical cysteine residue
within an acidic/basic or hydrophobic structural motif that may also be subject
to oxygen- or glutathione-dependent modification. NO-sensitive ion channels
including the cardiac and skeletal muscle ryanodine receptor (RyR1),
N-methyl-D-aspartate receptor (NMDAR) complex, cyclic-nucleotide gated ion
channel, are modulated by S-nitrosylation. S-nitrosylation of capsase-3 inhibits
apoptosis signaling. S-nitrosylation activates matrix metalloproteinase-9
(MMP-9) and induces neuronal apoptosis. The small G-protein p21Ras and Jun
kinase are regulated by S-nitrosylation. The activity of transcription factors
such as NF?B, c-jun, and c-fos is modulated by S-nitrosylation. In addition, the
formation of S-nitrosylated glutathione (GSNO) has been proposed to be one of
the major storage forms of NO in vivo.
|